SERPINH1 and fibrosis: Furthermore, these findings contrast not only published in vitro studies but also in vivo studies; antifibrotic effects of Serpinh1-targeting siRNA have been previously observed in various fibrosis models, such as pulmonary, hepatic, renal, peritoneal, and dermal fibrosis (12–17, 32, 33).